0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer
International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.603-604 [Peer Reviewed Journal]2006 2006 IGCS, International Journal of Gynecological Cancer ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-00009577-200610001-00017
Full text available